You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GnRH antagonist

Showing 2151 - 2167 of 2,167
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NIDDM Trial in Haifa (candesartan)

Unknown status
  • NIDDM
  • Haifa, Israel
    Internal Ward "A", Rambam Medical Center
Feb 22, 2006

Hot Flashes Trial in La Jolla (melatonin 0.5 mg)

Terminated
  • Hot Flashes
  • melatonin 0.5 mg
  • La Jolla, California
    Scripps Clinic Sleep Center
Feb 6, 2006

Hyperalgesia, Pain, Prostate Cancer Trial in Toronto (Amantadine)

Unknown status
  • Hyperalgesia
  • +2 more
  • Toronto, Ontario, Canada
    University Health Network
Mar 13, 2006

Postoperative Pain Trial in Taipei (Nalbuphine and morphine)

Unknown status
  • Postoperative Pain
  • Nalbuphine and morphine
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 22, 2005

Sepsis, Shock, Septic, Sepsis Syndrome Trial in United States (E5564)

Completed
  • Sepsis
  • +4 more
  • Mobile, Alabama
  • +16 more
Dec 8, 2005

Efficacy of Dextromethorphan, Morphine Consumption, Pain Trial in KhonKaen (pre-operatively followed by 30 mg three times per

Completed
  • Efficacy of Dextromethorphan
  • +2 more
  • pre-operatively followed by 30 mg three times per day after surgery
  • KhonKaen, Thailand
    Waraporn Chau-in
Sep 12, 2005

Gonadotropin-Releasing Hormone Pulse Frequency in Sexual

Completed
  • Hypogonadism
  • Precocious Puberty
    • Ann Arbor, Michigan
      University of Michigan Health Systems
    Jun 23, 2005

    Hypertension, Cardiovascular Diseases Trial in Kyoto (Candesartan cilexetil)

    Unknown status
    • Hypertension
    • Cardiovascular Diseases
    • Candesartan cilexetil
    • Kyoto, Yoshidakonoe-cho, Sakyo-ku, Kyoto, Japan
      Kyoto University
    Aug 8, 2005

    Opioid-Related Disorders Trial in Burlington (Buprenorphine)

    Completed
    • Opioid-Related Disorders
    • Burlington, Vermont
      Treatment Research Center
    Jun 23, 2005

    Opioid-Related Disorders Trial in Burlington (Buprenorphine)

    Completed
    • Opioid-Related Disorders
    • Burlington, Vermont
      Treatment Research Center
    Jun 23, 2005

    Opioid-Related Disorders Trial in Burlington (Buprenorphine)

    Completed
    • Opioid-Related Disorders
    • Burlington, Vermont
      Treatment Research Center
    Jun 23, 2005

    Opioid-Related Disorders Trial in Burlington (Buprenorphine)

    Completed
    • Opioid-Related Disorders
    • Burlington, Vermont
      Treatment Research Center
    Jun 23, 2005

    Opioid-Related Disorders Trial in Burlington (Buprenorphine)

    Completed
    • Opioid-Related Disorders
    • Burlington, Vermont
      Treatment Research Center
    Jun 23, 2005

    Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy

    Completed
    • Lipodystrophy
      • Galveston, Texas
        University of Texas Medical Branch
      Jun 23, 2005

      Porphyria Trial in Galveston (luteinizing hormone-releasing factor)

      Completed
      • Porphyria
      • luteinizing hormone-releasing factor
      • Galveston, Texas
        University of Texas Medical Branch
      Jun 23, 2005

      Growth Hormone-Releasing Hormone Antagonist on Growth Hormone

      Completed
      • Acromegaly
        • (no location specified)
        Jun 23, 2005

        Course and Early Outcome of Systemic Lupus Erythematosus: Nature

        Completed
        • Systemic Lupus Erythematosus
          • Birmingham, Alabama
          • +2 more
          Jun 23, 2005